医院价格加成模式与重大手术预后:2016-2019年全国住院患者样本回顾性观察研究
基于美国全国住院患者样本(2016-2019),纳入600,828例接受冠脉搭桥、腹主动脉瘤修复、全肺切除或重大胃肠手术的成人患者,按医院价格加成水平分为低、中、高三组。高加成医院更多为营利性机构,且与更高的院内并发症、非家庭出院及住院费用相关;中等加成医院也与并发症、院内死亡及费用升高相关。
要点
- 高加成医院更多为营利性、城市及中大型医院(均P<.001)。
- 高加成医院重大手术的院内并发症调整OR为1.07(1.05-1.08)。
- 高加成医院指数住院费用较低加成医院高50.3%。
核心结论
- 医院价格加成较高主要见于营利性机构,且与重大手术后的并发症、非家庭出院、住院时间延长及费用显著升高相关。
研究设计与样本
- 回顾性观察研究,使用2016-2019年全国住院患者样本(NIS),纳入600,828例接受冠脉搭桥、腹主动脉瘤修复、全肺切除或重大胃肠手术的成人患者,按医院价格加成分为低、中、高三组。
主要发现
- 高加成医院重大手术的院内并发症调整OR为1.07(1.05-1.08),非家庭出院调整OR为1.07(1.06-1.09),指数住院费用较低加成医院高50.3%。
- 中等加成医院手术与并发症调整OR 1.03(1.01-1.05)、院内死亡调整OR 1.07(1.03-1.12)及费用高24.7%(24.2%-25.3%)相关。
- 高加成医院更多为中型或大型(65.2% vs 63.2% vs 53.7%)、城市(86.2% vs 76.9% vs 54.9%)及营利性(36.0% vs 12.1% vs 5.1%)(均P<.001)。
临床怎么用
- 临床选择或转诊重大手术患者时,可关注医院价格加成水平作为机构定价策略的潜在标志。
- 高加成医院应加强围术期质量与安全改进,并提升价格透明度以促进公平可负担的诊疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Substantial variation in hospital price markups has raised concerns regarding value and equity in inpatient care. Markup levels may capture organizational pricing strategies and local market dynamics; however, in contemporary all-payer national cohorts spanning multiple high-risk major operations, their relationship with risk-adjusted perioperative quality and safety outcomes, discharge disposition, and resource utilization remains poorly defined. METHODS: Using the National Inpatient Sample (2016-2019), adults (aged ≥18 years) undergoing coronary artery bypass grafting, abdominal aortic aneurysm repair, pneumonectomy, or major gastrointestinal surgery were identified. Hospitals were categorized into low-markup hospital, moderate-markup hospital, and high-markup hospital categories. Outcomes included postoperative complications, length of stay, in-hospital mortality, non-home discharge, and total costs. RESULTS: Among 600,828 patients (coronary artery bypass grafting: 26.0%; abdominal aortic aneurysm repair: 13.2%; pneumonectomy: 8.2%; major gastrointestinal: 52.0%), 23.3% (n = 139,991) were treated at low-markup hospitals, 37.2% (n = 223,468) at moderate-markup hospitals, and 39.5% (n = 237,369) at high-markup hospitals. A total of 4,764 hospitals were included; high-markup hospitals were more often medium or large in size (high-markup hospitals: 65.2%; moderate-markup hospitals: 63.2%; low-markup hospitals: 53.7%), urban (high-markup hospitals: 86.2%; moderate-markup hospitals: 76.9%; low-markup hospitals: 54.9%), and for-profit (high-markup hospitals: 36.0%; moderate-markup hospitals: 12.1%; low-markup hospitals: 5.1%) (all P < .001). Major surgery at high-markup hospitals was associated with higher odds of in-hospital morbidity (adjusted odds ratio, 1.07 [1.05-1.08]), non-home discharge (adjusted odds ratio, 1.07 [1.06-1.09]), and 50.3% higher index hospitalization costs compared with low-markup hospitals. Surgery at moderate-markup hospitals was linked with greater odds of complications (adjusted odds ratio, 1.03 [1.01-1.05]), in-hospital mortality (adjusted odds ratio, 1.07 [1.03-1.12]), and 24.7% higher costs (24.2%-25.3%). CONCLUSION: Higher hospital markups were predominantly observed among for-profit institutions. High-markup hospitals demonstrated higher rates of complications, non-home discharge, longer hospital stays, and markedly higher costs. Greater price transparency and payment models that reward quality and value rather than charges are necessary to promote equitable and affordable care.
引用
- Angez M, Woldesenbet S, Chatzipanagiotou OP, et al. Hospital price markup patterns and outcomes after major surgery: A retrospective observational study of the National Inpatient Sample 2016-2019. Surgery. 2026. PMID: 42000682. doi:10.1016/j.surg.2026.110211
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。